查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855904

2025年全球免疫基因体学市场报告

Immunogenomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫基因组学市场发展迅速，预计从2024年的52.4亿美元成长到2025年的60.9亿美元，复合年增长率达16.3%。过去研究期间的成长与自体免疫疾病盛行率上升、个人化医疗需求增加、人们对免疫基因组学检测的认识不断提高、政府对医疗保健研究的资助以及生物技术和製药行业的扩张有关。

预计未来几年免疫基因组学市场将快速成长，到2029年市场规模将达到110亿美元，复合年增长率（CAGR）为15.9%。预测期内的成长主要得益于免疫基因组学疗法的广泛应用、精准医疗的不断推进、研发投入的增加、医疗基础设施的完善以及对诊断解决方案需求的不断增长。预测期内的关键趋势包括定序和基因型鉴定技术的进步、免疫基因组学检测方法的创新、生物资讯学和数据分析的进展、标靶治疗的开发以及人工智慧在免疫基因组学中的应用。

免疫基因组学是基因组学的一个分支，它研究个体的基因组成如何影响其免疫系统的功能。它专注于识别影响免疫反应、感染疾病和自体免疫疾病易感性以及免疫疗法和疫苗有效性的基因变异。

免疫基因组学的主要产品类型包括仪器、耗材、软体和服务。仪器是用于分析遗传物质和研究免疫系统的实验室设备，包括定序仪、微阵列扫描仪和细胞分选仪。所采用的技术包括次世代定序仪、微阵列和聚合酵素链锁反应）。应用领域涵盖肿瘤学、感染疾病、自体免疫疾病和移植等领域，公司服务于医院和诊所、研究机构、製药和生物技术公司以及其他终端用户。

美国在2025年春季突然提高关税，由此引发的贸易摩擦对医疗保健产业造成了严重衝击，尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为了应对这项挑战，医疗产业正在积极调整筹资策略，尽可能地促进本地生产，并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，该系列报告提供免疫基因组学市场统计数据，例如全球免疫基因组学市场规模、区域份额、市场份额及竞争对手、详细的市场细分、市场趋势和机会，以及在免疫基因组学行业取得成功所需的数据。本免疫基因组学市场研究报告对该行业的现状和未来发展趋势进行了详细分析，为您提供观点的全面资讯。

预计感染疾病的日益普及将推动免疫基因组学市场在不久的将来成长。感染疾病是由细菌、病毒、真菌和寄生虫等有害微生物引起的疾病，可透过直接或间接途径在人与人之间传播。这些疾病发病率的上升主要是由于全球旅行的增加，这促进了病原体跨境的快速传播。免疫基因组学透过精确分析宿主的免疫反应和遗传易感性，有助于感染疾病的管理。这种方法透过识别患者特异性的免疫因素，减少了治疗中的试验，从而改善了诊断、疫苗研发和个人化治疗策略。例如，英国卫生安全局在2024年2月报告称，英格兰的结核病病例数将在2023年比2022年的4380例增加10.7%，达到4850例。因此，感染疾病的增加正在推动免疫基因组学市场的成长。

免疫基因组学市场的主要企业正致力于开发尖端技术，例如单细胞转录组解决方案，以高分辨率分析免疫细胞多样性，并加深对复杂免疫反应的理解。单细胞转录组解决方案能够分析单一细胞内的全部RNA转录本，从而深入了解复杂组织内的基因表现模式和细胞异质性。例如，2022年10月，加州太平洋生物科学公司（Pacific Biosciences of California Inc.）与10x Genomics公司合作，并与麻省理工学院和哈佛大学博德研究所（Broad Institute of MIT and Harvard）共同推出了多重阵列定序（MAS-Seq）套件。这种高通量、高性价比的定序解决方案能够对单细胞RNA转录物进行全长分析，从而以极高的精度发现新的RNA异构体和突变。该技术透过连接cDNA分子，将定序通量提高了16倍，并可与10x Genomics的单细胞技术和PacBio定序仪无缝整合。该解决方案使研究人员能够探索异构体水平的细胞异质性，从而推进疾病研究和生物标记发现。

2025年1月，美国生物技术公司Adaptive Biotechnologies Corp.与NeoGenomics Laboratories Inc.达成合作，以提升其先进的免疫基因组学检测服务。此次合作旨在扩大血液肿瘤患者获得个人化微量残存疾病（MRD）监测的机会，并透过整合尖端定序和诊断技术，促进个别化治疗策略的製定，从而改善患者护理。 NeoGenomics Laboratories Inc.是一家总部位于美国的免疫基因组学检测服务公司。

免疫基因组学市场还包括提供免疫谱分析、生物资讯分析、生物标记发现和免疫疗法支持等服务的营业单位所获得的收入。市场价值还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。免疫基因组学市场还包括定序试剂套件、试剂、微阵列和生物资讯学工具的销售。该市场的价值是“出厂价”，即产品製造商或创建者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创建者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球免疫基因体学：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球免疫基因组学市场：成长率分析
  • 全球免疫基因体学市场表现：规模与成长，2019-2024年
  • 全球免疫基因组学市场预测：规模与成长，2024-2029年，2034年预测
  • 全球免疫基因体学：潜在市场规模 (TAM)

第六章 市场细分

  • 全球免疫基因组学市场（按产品类型划分）：实际数据和预测数据，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 装置
  • 消耗品
  • 软体
  • 服务
  • 全球免疫基因体学市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 次世代定序仪
  • 微阵列
  • 聚合酵素链锁反应
  • 其他技术
  • 全球免疫基因体学市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 肿瘤学
  • 感染疾病
  • 自体免疫疾病
  • 移植
  • 其他用途
  • 全球免疫基因组学市场：依最终用户划分，实际数据和预测数据，2019-2024年、2024-2029年预测数据、2034年预测数据
  • 医院和诊所
  • 研究所
  • 製药和生物技术公司
  • 其他最终用户
  • 全球免疫基因体学市场：依仪器、类型、表现和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 序列器
  • 微阵列扫描仪
  • 流式细胞仪
  • 全球免疫基因体学市场：按耗材、类型、实际值和预测值分類的细分市场，2019-2024年、2024-2029年预测值、2034年预测值
  • 试剂
  • 套件
  • 检测组
  • 全球免疫基因体学市场：依软体、类型、实际值及预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 数据分析软体
  • 生物资讯学工具
  • 视觉化平台
  • 全球免疫基因体学市场：按服务、类型、表现和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 定序服务
  • 基因组分析
  • 生物资讯支持

第七章 区域和国家分析

  • 全球免疫基因体学市场：区域表现及预测，2019-2024年、2024-2029年预测、2034年预测
  • 全球免疫基因体学市场：国家、市场表现及预测，2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 免疫基因体学市场：竞争格局
  • 免疫基因组学市场：公司概况
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • CareDx Inc.
  • Oxford Nanopore Technologies plc
  • Genewiz LLC
  • Adaptive Biotechnologies Corporation
  • GenomOncology LLC
  • Personalis Inc.
  • Variantyx Inc.
  • CD Genomics Inc.
  • Sengenics Corporation
  • GeneCentric Therapeutics Inc.
  • Immunogenomics Inc.
  • ImmuQuad Biotechnologies Inc.
  • Neomics Pharmaceuticals LLC
  • Yemaachi Biotech Ltd.
  • BioAnalytica Biotechnology Systems Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年免疫基因体学市场：提供新机会的国家
  • 2029年免疫基因体学市场：新兴细分市场机会
  • 2029年免疫基因体学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38553

Immunogenomics is a branch of genomics that examines how an individual's genetic makeup influences the immune system's function. It focuses on identifying genetic variations that impact immune responses, susceptibility to infections and autoimmune diseases, and the effectiveness of immunotherapies and vaccines.

The primary product types of immunogenomics include instruments, consumables, software, and services. Instruments are laboratory devices used to analyze genetic material and study the immune system, including sequencers, microarray scanners, and cell sorters. Technologies employed include next-generation sequencing, microarray, polymerase chain reaction, and others. Applications span oncology, infectious diseases, autoimmune disorders, transplantation, and more, serving hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The immunogenomics market research report is one of a series of new reports from The Business Research Company that provides immunogenomics market statistics, including immunogenomics industry global market size, regional shares, competitors with an immunogenomics market share, detailed immunogenomics market segments, market trends and opportunities, and any further data you may need to thrive in the immunogenomics industry. This immunogenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunogenomics market size has grown rapidly in recent years. It will grow from $5.24 billion in 2024 to $6.09 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be linked to rising prevalence of autoimmune diseases, increasing demand for personalized medicine, greater awareness of immunogenomic testing, government funding for healthcare research, and expansion of the biotechnology and pharmaceutical sectors.

The immunogenomics market size is expected to see rapid growth in the next few years. It will grow to $11.00 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be linked to wider adoption of immunogenomic-based therapies, expansion of precision medicine initiatives, increased investment in research and development, growth of healthcare infrastructure, and rising demand for diagnostic solutions. Key trends during the forecast period include advancements in sequencing and genotyping technologies, innovations in immunogenomic assays, progress in bioinformatics and data analysis, development of targeted therapies, and integration of artificial intelligence in immunogenomics.

The rising prevalence of infectious diseases is expected to drive the growth of the immunogenomics market in the near future. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, that can spread directly or indirectly from one person to another. The increasing frequency of these diseases is largely attributed to greater global travel, which facilitates the rapid transmission of pathogens across borders. Immunogenomics aids in managing infectious diseases by providing a precise analysis of host immune responses and genetic susceptibility. This approach reduces the trial-and-error nature of treatments by identifying patient-specific immune factors, which helps improve diagnostics, vaccine development, and personalized therapeutic strategies. For example, in February 2024, the UK Health Security Agency reported a 10.7% increase in tuberculosis cases in England, with 4,850 cases in 2023 compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is fueling the growth of the immunogenomics market.

Leading companies in the immunogenomics market are focusing on developing advanced technologies, such as single-cell transcriptome solutions, to provide high-resolution analysis of immune cell diversity and enhance the understanding of complex immune responses. Single-cell transcriptome solutions analyze the complete set of RNA transcripts in individual cells, offering insights into gene expression patterns and cellular heterogeneity within complex tissues. For example, in October 2022, Pacific Biosciences of California Inc. partnered with the Broad Institute of MIT and Harvard, along with 10x Genomics Inc., to launch a Multiplexed Arrays Sequencing (MAS-Seq) kit. This high-throughput, cost-effective sequencing solution enables the full-length analysis of single-cell RNA transcripts, uncovering novel RNA isoforms and mutations with exceptional accuracy. The technology increases sequencing throughput by 16 times by concatenating cDNA molecules and integrates seamlessly with 10x Genomics' single-cell technology and PacBio sequencers. This solution allows researchers to explore cellular heterogeneity at the isoform level, advancing disease research and biomarker discovery.

In January 2025, Adaptive Biotechnologies Corp., a US-based biotechnology firm, partnered with NeoGenomics Laboratories Inc. to enhance advanced immunogenomic testing services. This collaboration aims to expand access to personalized minimal residual disease (MRD) monitoring for blood cancer patients, facilitating tailored treatment strategies and improving patient care through the integration of cutting-edge sequencing and diagnostic technologies. NeoGenomics Laboratories Inc. is a US-based company that specializes in immunogenomics testing services.

Major players in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., and BioAnalytica Biotechnology Systems Inc.

North America was the largest region in the immunogenomics market in 2024. The regions covered in immunogenomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunogenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunogenomics market also consists of revenues earned by entities by providing services such as immune profiling, bioinformatics analysis, biomarker discovery, and immunotherapy support. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunogenomics market also includes sales of sequencing kits, reagents, microarrays, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunogenomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunogenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunogenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunogenomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Consumables; Software; Services
  • 2) By Technology: Next-Generation Sequencing; Microarray; Polymerase Chain Reaction; Other Technologies
  • 3) By Application: Oncology; Infectious Diseases; Autoimmune Disorders; Transplantation; Other Applications
  • 4) By End-User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Instruments: Sequencers; Microarray scanners; Flow cytometers
  • 2) By Consumables: Reagents; Kits; Assay panels
  • 3) By Software: Data analysis software; Bioinformatics tools; Visualization platforms
  • 4) By Services: Sequencing services; Genomic profiling; Bioinformatics support
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Illumina Inc.; BGI Group; GenScript Biotech Corporation; CareDx Inc.; Oxford Nanopore Technologies plc; Genewiz LLC; Adaptive Biotechnologies Corporation; GenomOncology LLC; Personalis Inc.; Variantyx Inc.; CD Genomics Inc.; Sengenics Corporation; GeneCentric Therapeutics Inc.; Immunogenomics Inc.; ImmuQuad Biotechnologies Inc.; Neomics Pharmaceuticals LLC; Yemaachi Biotech Ltd.; BioAnalytica Biotechnology Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunogenomics Market Characteristics

3. Immunogenomics Market Trends And Strategies

4. Immunogenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunogenomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunogenomics Market Growth Rate Analysis
  • 5.4. Global Immunogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunogenomics Total Addressable Market (TAM)

6. Immunogenomics Market Segmentation

  • 6.1. Global Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Software
  • Services
  • 6.2. Global Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Other Technologies
  • 6.3. Global Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Infectious Diseases
  • Autoimmune Disorders
  • Transplantation
  • Other Applications
  • 6.4. Global Immunogenomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users
  • 6.5. Global Immunogenomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencers
  • Microarray scanners
  • Flow cytometers
  • 6.6. Global Immunogenomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Kits
  • Assay panels
  • 6.7. Global Immunogenomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data analysis software
  • Bioinformatics tools
  • Visualization platforms
  • 6.8. Global Immunogenomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing services
  • Genomic profiling
  • Bioinformatics support

7. Immunogenomics Market Regional And Country Analysis

  • 7.1. Global Immunogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunogenomics Market

  • 8.1. Asia-Pacific Immunogenomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunogenomics Market

  • 9.1. China Immunogenomics Market Overview
  • 9.2. China Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunogenomics Market

  • 10.1. India Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunogenomics Market

  • 11.1. Japan Immunogenomics Market Overview
  • 11.2. Japan Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunogenomics Market

  • 12.1. Australia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunogenomics Market

  • 13.1. Indonesia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunogenomics Market

  • 14.1. South Korea Immunogenomics Market Overview
  • 14.2. South Korea Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunogenomics Market

  • 15.1. Western Europe Immunogenomics Market Overview
  • 15.2. Western Europe Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunogenomics Market

  • 16.1. UK Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunogenomics Market

  • 17.1. Germany Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunogenomics Market

  • 18.1. France Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunogenomics Market

  • 19.1. Italy Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunogenomics Market

  • 20.1. Spain Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunogenomics Market

  • 21.1. Eastern Europe Immunogenomics Market Overview
  • 21.2. Eastern Europe Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunogenomics Market

  • 22.1. Russia Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunogenomics Market

  • 23.1. North America Immunogenomics Market Overview
  • 23.2. North America Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunogenomics Market

  • 24.1. USA Immunogenomics Market Overview
  • 24.2. USA Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunogenomics Market

  • 25.1. Canada Immunogenomics Market Overview
  • 25.2. Canada Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunogenomics Market

  • 26.1. South America Immunogenomics Market Overview
  • 26.2. South America Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunogenomics Market

  • 27.1. Brazil Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunogenomics Market

  • 28.1. Middle East Immunogenomics Market Overview
  • 28.2. Middle East Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunogenomics Market

  • 29.1. Africa Immunogenomics Market Overview
  • 29.2. Africa Immunogenomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunogenomics Market Competitive Landscape And Company Profiles

  • 30.1. Immunogenomics Market Competitive Landscape
  • 30.2. Immunogenomics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Immunogenomics Market Other Major And Innovative Companies

  • 31.1. CareDx Inc.
  • 31.2. Oxford Nanopore Technologies plc
  • 31.3. Genewiz LLC
  • 31.4. Adaptive Biotechnologies Corporation
  • 31.5. GenomOncology LLC
  • 31.6. Personalis Inc.
  • 31.7. Variantyx Inc.
  • 31.8. CD Genomics Inc.
  • 31.9. Sengenics Corporation
  • 31.10. GeneCentric Therapeutics Inc.
  • 31.11. Immunogenomics Inc.
  • 31.12. ImmuQuad Biotechnologies Inc.
  • 31.13. Neomics Pharmaceuticals LLC
  • 31.14. Yemaachi Biotech Ltd.
  • 31.15. BioAnalytica Biotechnology Systems Inc.

32. Global Immunogenomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunogenomics Market

34. Recent Developments In The Immunogenomics Market

35. Immunogenomics Market High Potential Countries, Segments and Strategies

  • 35.1 Immunogenomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunogenomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunogenomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer